Why Elan Is Inviting Royalty Pharma Bid

June 17 (Bloomberg) -- Elan Corp. is seeking a buyer and will invite Royalty Pharma, whose $6.7 billion bid it rejected, to participate, suggesting the two companies may end a standoff that has lasted almost four months. Jonathan Ferro reports on Bloomberg Television's "Countdown." (Source: Bloomberg)

Most Recent Videos

The Top Stocks to Watch in Asia Today
50:35 - Jan. 30 -- In today’s “Stock Exchange,” Bloomberg’s John Dawson and Yvonne Man discuss today’s top stocks to watch in Asia on “First Up.”
  • Fed Is in No Mood to Spoil the Market Party: Sri-Kumar
  • Walt Disney's "Tomorrowland" Gets Super Bowl Trailer
  • Amazon Sales Rose 15% in Fourth Quarter